MetLife Inc stock (US59156R1086): Insider Form 144 filing and Q1 earnings shape Tuesday trading

MetLife Inc shares on the New York Stock Exchange traded around the low-USD 80s on 06/02/2026, edging modestly lower compared with the prior close as investors weighed an insider Form 144 filing alongside the insurer’s recently reported Q1 2026 earnings performance in the United States market.

The stock traded at about USD 81.50 on 06/02/2026 on the NYSE under the ticker MET, compared with a prior close near USD 82.70, implying a mild single-day decline of roughly 1.5 percent according to pricing data referenced by Moneycontrol as of 06/02/2026, while the issue continues to be part of the US large-cap financials universe.

As of: 06/02/2026

By the editorial team - specialized in equity coverage.

In the United States, MetLife remains closely watched because of its scale in life insurance and retirement solutions, and NYSE trading in MET often tracks broader financial-sector sentiment as well as company-specific earnings and capital-management disclosures.

MetLife Inc: core business model

MetLife generates most of its revenue by offering a broad suite of life insurance, group benefits, retirement products, and asset management services to individual and institutional customers across its key regions, with premium income and fee-based earnings tied to policy volumes, persistency, and investment spreads.

Recent corporate actions

On 06/01/2026, a Rule 144 notice was filed for MetLife common stock reporting proposed sales of an aggregate 21,312 shares linked to stock options granted on 02/28/2017 and 03/02/2018, according to a summary of the filing hosted by Stock Titan as of 06/01/2026. The Form 144 excerpt shows two line items of 10,600 and 10,712 shares, each associated with earlier equity awards and listed with cash settlement, indicating that an insider or affiliated holder plans to sell a relatively small block of MET shares into the market under Rule 144 on or after that date. While the filing size is limited relative to MetLife’s overall market capitalization, such disclosures provide additional transparency on insider-related share flows and can be monitored by investors as part of broader governance and liquidity analysis.

Latest quarterly results for MetLife Inc at a glance

MetLife’s most recent quarterly figures show that earnings remain a key anchor for the stock’s valuation as of early June 2026. For Q1 2026, MetLife reported revenue of about USD 19.1 billion and net income of roughly USD 1.19 billion, according to a results overview cited by Simply Wall St based on company disclosures as of 05/2026. These figures underpin MetLife’s ability to support dividends and capital deployment, and they follow a prior period in which the insurer had also reported a return on equity above 20 percent and a net margin in the mid-single digits, as highlighted in recent coverage of the company’s financial metrics. The combination of solid top-line scale and profitability metrics has kept the focus on how MetLife balances growth, risk management, and capital returns in a higher-rate environment.

The Q1 2026 numbers also come against a backdrop of active institutional positioning in MetLife shares. An example is MUFG Securities EMEA plc, which sharply increased its stake in MetLife in the fourth quarter, lifting holdings by 1,185.9 percent to 137,490 shares valued at about USD 10.85 million, according to MarketBeat coverage of institutional filings as of 06/01/2026. Such moves by large investors can contribute to liquidity and signal evolving views on the insurer’s earnings resilience, although individual institutional decisions are only one part of the broader shareholder mix.

Beyond institutional flows, MetLife has also been refining its product set, including work on new annuity features discussed in recent analysis that referenced the company’s Q1 2026 performance and strategic initiatives. These developments, combined with earnings data and insider filings such as the recent Form 144 notice, feed into how market participants assess both the near-term trading profile of MET shares on the NYSE and the longer-term trajectory of the business.

Conclusion

MetLife shares on the NYSE spent Tuesday trading slightly below the prior close as investors digested a new Rule 144 filing that outlines planned insider-related sales of just over 21,000 shares against the backdrop of a large US insurance franchise. The latest Q1 2026 figures, which showed revenue of roughly USD 19.1 billion and net income near USD 1.19 billion, remain central to how market participants view the company’s ability to generate capital for dividends and other uses. Together, earnings quality, documented insider activity, and visible institutional positioning continue to inform how the market prices MetLife within the broader United States financials sector.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.